With over three decades of experience manufacturing injectable trace elements, American Regent understands the importance of ensuring a consistent supply of our products to the parenteral nutrition market. We are committed to updating our trace element product line to better align with ASPEN’s current nutritional guidelines.

As of today, we have introduced the first FDA-approved multi-trace element formulation, Tralement® (trace elements injection 4*, USP), the first FDA-approved Selenious Acid Injection, and a family of FDA-approved Zinc Sulfate Injection, USP, products. Pending FDA approval of one additional trace element product, we expect that our entire trace element product line will consist of FDA-approved products.

American Regent, Inc., a Daiichi Sankyo Group company, is a top-10 injectable manufacturer. For more than 50 years, American Regent has been developing, manufacturing, and supplying quality generic and branded injectables for healthcare providers. For nearly 20 years, we have been a leader in IV iron therapy, supplying two of the top-selling brands in the US today.

*Each mL provides zinc 3 mg, copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.